title: A nuclear-receptor-dependent phosphatidylcholine pathway with antidiabetic effects.
abstract: Nuclear hormone receptors regulate diverse metabolic pathways and the orphan nuclear receptor LRH-1 (also known as NR5A2) regulates bile acid biosynthesis. Structural studies have identified phospholipids as potential LRH-1 ligands, but their functional relevance is unclear. Here we show that an unusual phosphatidylcholine species with two saturated 12 carbon fatty acid acyl side chains (dilauroyl phosphatidylcholine (DLPC)) is an LRH-1 agonist ligand in vitro. DLPC treatment induces bile acid biosynthetic enzymes in mouse liver, increases bile acid levels, and lowers hepatic triglycerides and serum glucose. DLPC treatment also decreases hepatic steatosis and improves glucose homeostasis in two mouse models of insulin resistance. Both the antidiabetic and lipotropic effects are lost in liver-specific Lrh-1 knockouts. These findings identify an LRH-1 dependent phosphatidylcholine signalling pathway that regulates bile acid metabolism and glucose homeostasis.
authors: Program in Developmental Biology, Baylor College of Medicine, Houston, Texas 77030, USA.
authors: Jae Man
authors: JM
authors: Lee
authors: Yoon Kwang
authors: YK
authors: Lee
authors: Jennifer L
authors: JL
authors: Mamrosh
authors: Scott A
authors: SA
authors: Busby
authors: Patrick R
authors: PR
authors: Griffin
authors: Manish C
authors: MC
authors: Pathak
authors: Eric A
authors: EA
authors: Ortlund
authors: David D
authors: DD
authors: Moore
references: J Biol Chem. 1999 Jul 23;274(30):20869-73
references: 10409629
references: Curr Opin Endocrinol Diabetes Obes. 2009 Apr;16(2):141-9
references: 19262374
references: Proc Natl Acad Sci U S A. 2009 Nov 3;106(44):18831-6
references: 19850873
references: J Clin Invest. 2006 Apr;116(4):1102-9
references: 16557297
references: Mol Cell Biol. 2005 May;25(9):3492-505
references: 15831456
references: J Biol Chem. 2000 Oct 6;275(40):31078-85
references: 10918064
references: Proc Natl Acad Sci U S A. 2003 Jan 7;100(1):131-6
references: 12502787
references: Proc Natl Acad Sci U S A. 2004 Apr 27;101(17):6409-14
references: 15096593
references: Mol Endocrinol. 2009 Jan;23(1):25-34
references: 18988706
references: Circ Res. 2000 Sep 15;87(6):516-21
references: 10988245
references: Science. 1992 Oct 30;258(5083):766-70
references: 1439783
references: Nat Struct Mol Biol. 2005 Apr;12(4):357-63
references: 15723037
references: Mol Cell Biol. 2005 Jun;25(12):5095-105
references: 15923626
references: Proc Natl Acad Sci U S A. 2010 Feb 23;107(8):3441-6
references: 20133650
references: J Biol Chem. 2007 Apr 6;282(14):10290-8
references: 17283069
references: Mol Cell Biol. 2007 Dec;27(23):8330-9
references: 17908794
references: Proc Natl Acad Sci U S A. 2005 May 24;102(21):7505-10
references: 15897460
references: Trends Endocrinol Metab. 2010 Jul;21(7):449-56
references: 20338778
references: Cell. 2009 Aug 7;138(3):476-88
references: 19646743
references: Mol Endocrinol. 2008 Jun;22(6):1345-56
references: 18323469
references: J Med Chem. 2006 Nov 16;49(23):6652-5
references: 17154495
references: ChemMedChem. 2011 Jan 3;6(1):94-103
references: 21162086
references: Annu Rev Nutr. 1997;17:77-99
references: 9240920
references: J Clin Invest. 2006 Mar;116(3):817-24
references: 16485039
references: Mol Cell Biol. 2007 Oct;27(19):6669-85
references: 17664281
references: J Clin Invest. 2004 May;113(10):1408-18
references: 15146238
references: Mol Cell. 2005 Feb 18;17(4):491-502
references: 15721253
references: J Biol Chem. 2006 Mar 24;281(12):7850-5
references: 16439367
references: Cell. 2005 Feb 11;120(3):343-55
references: 15707893
references: J Cell Biochem. 2006 Feb 1;97(2):244-51
references: 16240373
references: Proc Natl Acad Sci U S A. 1999 Nov 23;96(24):13656-61
references: 10570128
references: Endocrinology. 2006 Nov;147(11):5249-58
references: 16887917